RELA, RELA proto-oncogene, NF-kB subunit, 5970

N. diseases: 483; N. variants: 11
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C4048328
Disease: cervical cancer
cervical cancer
0.060 Biomarker disease BEFREE The peptidyl-prolyl isomerase Pin1 is correlated with the progression of cervical cancer via regulating numerous oncogenic and tumor suppressor pathways. p65 is a crucial regulator of tumorigenesis that is regulated by Pin1, and p65 signaling suppression can enhance the antitumor efficacy of doxorubicin (DOX). 31460012 2019
CUI: C4048328
Disease: cervical cancer
cervical cancer
0.060 Biomarker disease BEFREE On the whole, the synchronous co‑expression of Id‑1 and nuclear NF‑κB p65 has a prominent role in cervical cancer, suggesting a combined analysis of Id‑1 and NF‑κB may help to predict malignant properties and prognosis. 31545447 2019
CUI: C4048328
Disease: cervical cancer
cervical cancer
0.060 AlteredExpression disease BEFREE This was achieved by studying the expression of two signalling molecules expressed in cervical cancer; MUC1 and P65. 25960241 2015
CUI: C4048328
Disease: cervical cancer
cervical cancer
0.060 AlteredExpression disease BEFREE We found both the membrane expression of CFTR and nuclear translocation of NF-κB p65 were progressively increased from normal cervical tissue, cervical intraepithelial neoplasm, to cervical cancer (overall R² = 0.74, P < 0.001). 23640294 2013
CUI: C4048328
Disease: cervical cancer
cervical cancer
0.060 Biomarker disease BEFREE Thus, these results provided evidence that STC1 inhibited cell proliferation and invasion through NF-κB p65 activation in cervical cancer. 23382863 2013
CUI: C4048328
Disease: cervical cancer
cervical cancer
0.060 AlteredExpression disease BEFREE Features of Notch1 activation as measured by intracellular Notch1, high levels of Jagged1, Hes1 and Cdk9 were paralleled by nuclear translocation of both NF-kappaB p50 and p65 with target gene expression (IkappaB-alpha, Bcl-2, and CyclinD1) in human cervical cancer sections. 17098279 2007